Thermo Fisher Scientific Inc (TMO) - Medical Equipment - Deals and Alliances Profile

Date: July 12, 2017
Pages: 249
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T82913090F3EN
Leaflet:

Download PDF Leaflet

Thermo Fisher Scientific Inc (TMO) - Medical Equipment - Deals and Alliances Profile
Summary

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It also delivers a broad selection of analytical instruments, equipment, consumables and laboratory supplies. The company serves pharmaceutical and biotech companies, universities, hospitals and clinical diagnostic labs, research institutions and government agencies; and environmental, industrial quality and process control sectors. It also offers various specialty brands that cover a range of consumable products for the life and laboratory sciences industry. It sells its products and services through direct sales force, customer-service professionals, electronic commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Massachusetts, the US.

Thermo Fisher Scientific Inc (TMO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deal Details
Asset Purchase
Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For US$15 Million
Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics
Venture Financing
KonTEM Raises Funds Through Venture Financing
Private Equity
GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million
Partnerships
One Lambda Enters into Licensing Agreement with Transcriptome Sciences
Singulex Enters into Licensing agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology
Affymetrix Enters into Licensing Agreement with Peptide Groove
diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests
Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells
Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin
Vela Diagnostics Enters Into Licensing Agreement With Life Technologies
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries
Affymetrix Enters Into Licensing Agreement With Genisphere
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere
Seegene Enters into Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Agreement with Agios Pharma
Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital
Asuragen Enters into Agreement with Thermo Fisher Scientific
Invivoscribe Enters into Agreement with Thermo Fisher Scientific
Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies
Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed
Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome
Strata Oncology Enters into Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Partners with University of Birmingham
HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies
Thermo Fisher Scientific Enters into Co-Development Agreement with Children’s Hospital Los Angeles
Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific
Affymetrix Enters into Agreement with Reveal Biosciences
Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific
XRGenomics Enters into Research Agreement with Affymetrix
Affymetrix Enters into Distribution Agreement with Luminex
Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific
Cytox Enters into Joint Development Partnership with Affymetrix
Atossa Genetics Enters into Distribution Agreement with Thermo Fisher
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems
Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics
Ingen Expands Distribution Agreement with One Lambda
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer
Lucigen Enters into Agreement with Thermo Fisher Scientific
Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University
Affymetrix Enters Into Integration Agreement With CollabRx
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics
Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing
Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment
Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools
Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham
Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test
Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare
BioDesign Institute Enters Into Co-Development Agreement With Life Technologies
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay
Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics
Biocept Enters into Partnership with Life Technologies
Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik
Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions
CollabRx Enters Into Co-Development Agreement With Life Technologies
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing
Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx
Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance
Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies
One Lambda Enters Into Co-Marketing Agreement With CellTrend
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
Iris International Enters Into Distribution Agreement With Fisher HealthCare
IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare
Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs
Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific
Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis
Life Technologies Enters Into Joint Venture Agreement With DaAn Gene
InGen BioSciences Enters into Distribution Agreement with One Lambda
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals
Sage Science Enters Into Co-Marketing Agreement With Life Technologies
Life Technologies Enters Into Co-Marketing Agreement With Quidel
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement
Luminex Enters Into Distribution Agreement With Life Technologies
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics
Rapid Micro Biosystems Enters Into Co-Marketing Agreement With Life Technologies
Affymetrix Enters Into Distribution Agreement With Thermo Fisher
Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs
Life Technologies Enters Into Licensing Agreement With Novartis
Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software
Equity Offering
Affymetrix to Raise USD50 Million in Private Placement of Shares
Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million
Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million
Debt Offering
Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million
Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes
Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028
Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028
Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023
Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025
Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018
Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020
Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022
Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025
Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million
Thermo Fisher Scientific Completes Public Offering Of 2.250% Senior Notes Due 2016 For US$1,000 Million
Thermo Fisher Scientific Completes Public Offering Of 3.600% Senior Notes Due 2021 For US$1,100 Million
Thermo Fisher Scientific Announces Public Offering Of Senior Notes Due 2022
Thermo Fisher Scientific Completes Public Offering Of 4.500% Senior Notes Due 2021 For US$1,000 Million
Thermo Fisher Scientific Completes Public Offering Of 2.050% Senior Notes Due 2014 For US$300 Million
Thermo Fisher Scientific Completes Public Offering Of 3.200% Senior Notes Due 2016 For US$900 Million
Acquisition
Thermo Fisher Scientific Acquires Finesse Solutions
Thermo Fisher Scientific Acquires FEI for USD4.2 Billion
Thermo Fisher Scientific May Acquire Illumina for USD30 Billion
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion
Thermo Fisher Scientific Acquires INEL
Thermo Fisher Scientific Acquires Advanced Scientifics for USD300 Million
FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM
EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion
FEI Company To Acquire nanoTechnology Systems
Life Technologies Acquires KDR Biotech, Distributor Of Reagents
Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer
Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes
Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For US$925 Million
FEI Acquires Visualization Sciences, 3D Visualization Software Company, For US$55 Million
Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company
Life Technologies Acquires Navigenics
Affymetrix Completes Acquisition Of eBioscience For US$315 Million
Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience
FEI Company Acquires TILL Photonics For US$19.9 Million
Thermo Fisher Scientific Acquires Intrinsic Bioprobes
Thermo Fisher Completes Acquisition Of Phadia
Thermo Fisher Scientific Acquires TREK Diagnostic Systems
Thermo Fisher Scientific Acquires Sterilin
Thermo Fisher Scientific Completes The Acquisition Of Dionex
Quest Diagnostics Completes Acquisition Of Athena Diagnostics
Thermo Fisher Scientific Inc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results
Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results
Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results
Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results
Apr 28, 2016: Thermo Fisher Scientific Reports First Quarter 2016 Results
Jan 28, 2016: Thermo Fisher Scientific Reports Record Fourth Quarter and Full Year 2015 Results
Corporate Communications
Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board
May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility
Jan 27, 2016: Orbitrap Fusion Lumos Tribrid Mass Spectrometer Wins Scientists’ Choice Award for Best New Drug Discovery Product of 2015
Legal and Regulatory
Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories
Product News
Jun 29, 2017: New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections
Jun 05, 2017: Thermo Fisher Scientific and BIOCRATES Life Sciences Launch Industry’s First Kit for Comprehensive Metabolome Analysis
Jun 02, 2017: Newly Redesigned Panels Align with Most Recent Published Evidence to Drive Cancer Research
May 24, 2017: New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost
May 22, 2017: Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis Technology with new Applied Biosystems SeqStudio Genetic Analyzer
Mar 21, 2017: New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease
Mar 20, 2017: Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at INTERPHEX
Nov 01, 2016: Angsana provides tests for allergen sensitization specific for Asian population
Oct 18, 2016: Thermo Fisher Scientific Announces Next-Generation Transcriptome Profiling Assays for Fast Biomarker Discovery
Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution
Aug 01, 2016: Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016
Aug 01, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease
Jul 25, 2016: Advanced Software Package Designed to Reduce Sample Analysis Time for Analytical Microscope Users
Jul 19, 2016: New system uses electrical conductivity to measure dry blood samples used in infant HIV screening, testing for metabolic disorders
Jul 07, 2016: Thermo Fisher Scientific Announces Next-Generation Sequencing Assay for Liquid Biopsy Research
Jun 28, 2016: Thermo Fisher Scientific Features Capabilities to Advance Future of Precision Medicine at Festival of Genomics
Jun 17, 2016: Thermo Fisher Scientific Workshop Session and Poster Presentation at ASM Microbe 2016
May 16, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease
May 12, 2016: Thermo Fisher Scientific: Second Generation Cell Imaging System Enables Higher-Quality Experiments
May 10, 2016: Native Mobile Capabilities Added to Thermo Scientific SampleManager LIMS
May 10, 2016: New Instruments and Software, iCAP RQ ICP-MS spectrometer and Qtegra Intelligent Scientific Data Solution software Designed to Improve Trace Elemental Analysis
May 10, 2016: New UHPLC-MS Workflows, protein analysis kits, columns and software Designed for Biopharmaceutical Characterization
Apr 26, 2016: Thermo Fisher Scientific Strengthens Bioprocessing Capabilities with New Products at INTERPHEX 2016
Mar 16, 2016: Thermo Fisher Scientific Launches New Forensic Enterprise Software
Mar 07, 2016: New Easy-to-Use Microscopes Bring the Benefits of Raman Spectroscopy to More Analytical Labs
Mar 07, 2016: New FT-NIR Spectrometer is Lightweight, Compact and Cost-Effective
Mar 07, 2016: New High-Pressure Ion Chromatography System Delivers New Levels of Simplicity and Flexibility
Mar 07, 2016: New Instruments and Software Designed to Improve Trace Elemental Analysis
Mar 07, 2016: New UHPLC Columns Offer Users Expanded Application Flexibility
Mar 07, 2016: New UHPLC-MS Workflows Designed for Biopharmaceutical Characterization
Mar 07, 2016: New UV-Vis Spectrophotometers Make it Easier to Determine Sample Quality and Suitability
Mar 07, 2016: New Visible-Range Spectrophotometer Enables Colorimetric Analysis in Education and QA/QC
Mar 07, 2016: Thermo Fisher Scientific Continues to Expand Leading Analytical Instruments Offering for Customers in Applied Markets
Mar 01, 2016: Accurately Detect Volatile Organic Compounds in Manufactured Products
Mar 01, 2016: Thermo Fisher Scientific Announces Expanded FDA Clearance for its B·R·A·H·M·S PCT Sepsis Biomarker
Feb 23, 2016: Thermo Fisher Scientific Exhibits ClinQuan MD Software for In Vitro Diagnostic Use at MSACL 2016
Feb 23, 2016: Thermo Fisher Scientific Exhibits Endura MD Mass Spectrometer for In Vitro Diagnostic Use at MSACL 2016
Feb 23, 2016: Thermo Fisher Scientific Exhibits Prelude MD HPLC for In Vitro Diagnostic Use at MSACL 2016
Feb 22, 2016: Thermo Fisher Scientific Offers EUROIMMUN Anti-Zika Virus Test Kits
Feb 18, 2016: Children’s Hospital Los Angeles Announces Development of Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer Research
Feb 04, 2016: New Benchtop Centrifuge Incorporates Hybrid Rotor for Application Flexibility
Jan 28, 2016: Thermo Fisher Scientific brings in Europe a new B · R · A · H · M · S PCT test for the Samsung IB10 Point-of-care platform on the market
Jan 27, 2016: New Nano LC System with ProFlow Technology Offers Advanced Low-flow Performance
Product Approvals
Mar 01, 2016: Thermo Fisher Scientific Announces Expanded FDA Clearance for its B·R·A·H·M·S PCT Sepsis Biomarker
Other Significant Developments
Jun 12, 2017: Allergen Sensitization Testing Breakthrough Marks 50th Anniversary
Oct 17, 2016: Thermo Fisher Scientific Joins Cancer Moonshot Effort
Jul 18, 2016: Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP Allergy Testing Products
Jun 01, 2016: Ion Torrent Developers Alliance Program Designed to Speed Targeted NGS Assay Development
Feb 17, 2016: Next-Generation Large Molecule Affinity Purification Solution Improves Biotherapeutic, Disease Biomarker and Sports Anti-Doping Bioanalysis
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Thermo Fisher Scientific Inc, Medical Equipment, Key Facts, 2016
Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Deals By Market, 2011 to YTD 2017
Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For US$15 Million
Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics
KonTEM Raises Funds Through Venture Financing
GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million
One Lambda Enters into Licensing Agreement with Transcriptome Sciences
Singulex Enters into Licensing agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology
Affymetrix Enters into Licensing Agreement with Peptide Groove
diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests
Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells
Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin
Vela Diagnostics Enters Into Licensing Agreement With Life Technologies
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries
Affymetrix Enters Into Licensing Agreement With Genisphere
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere
Seegene Enters into Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Agreement with Agios Pharma
Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital
Asuragen Enters into Agreement with Thermo Fisher Scientific
Invivoscribe Enters into Agreement with Thermo Fisher Scientific
Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies
Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed
Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome
Strata Oncology Enters into Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Partners with University of Birmingham
HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies
Thermo Fisher Scientific Enters into Co-Development Agreement with Children’s Hospital Los Angeles
Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific
Affymetrix Enters into Agreement with Reveal Biosciences
Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific
XRGenomics Enters into Research Agreement with Affymetrix
Affymetrix Enters into Distribution Agreement with Luminex
Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific
Cytox Enters into Joint Development Partnership with Affymetrix
Atossa Genetics Enters into Distribution Agreement with Thermo Fisher
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems
Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics
Ingen Expands Distribution Agreement with One Lambda
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer
Lucigen Enters into Agreement with Thermo Fisher Scientific
Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific
Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University
Affymetrix Enters Into Integration Agreement With CollabRx
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics
Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing
Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment
Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools
Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham
Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test
Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare
BioDesign Institute Enters Into Co-Development Agreement With Life Technologies
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay
Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics
Biocept Enters into Partnership with Life Technologies
Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik
Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions
CollabRx Enters Into Co-Development Agreement With Life Technologies
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing
Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx
Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance
Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies
One Lambda Enters Into Co-Marketing Agreement With CellTrend
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
Iris International Enters Into Distribution Agreement With Fisher HealthCare
IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare
Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs
Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific
Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis
Life Technologies Enters Into Joint Venture Agreement With DaAn Gene
InGen BioSciences Enters into Distribution Agreement with One Lambda
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals
Sage Science Enters Into Co-Marketing Agreement With Life Technologies
Life Technologies Enters Into Co-Marketing Agreement With Quidel
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement
Luminex Enters Into Distribution Agreement With Life Technologies
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics
Rapid Micro Biosystems Enters Into Co-Marketing Agreement With Life Technologies
Affymetrix Enters Into Distribution Agreement With Thermo Fisher
Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs
Life Technologies Enters Into Licensing Agreement With Novartis
Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software
Affymetrix to Raise USD50 Million in Private Placement of Shares
Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million
Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million
Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million
Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes
Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028
Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028
Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023
Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025
Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018
Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020
Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022
Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025
Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million
Thermo Fisher Scientific Completes Public Offering Of 2.250% Senior Notes Due 2016 For US$1,000 Million
Thermo Fisher Scientific Completes Public Offering Of 3.600% Senior Notes Due 2021 For US$1,100 Million
Thermo Fisher Scientific Announces Public Offering Of Senior Notes Due 2022
Thermo Fisher Scientific Completes Public Offering Of 4.500% Senior Notes Due 2021 For US$1,000 Million
Thermo Fisher Scientific Completes Public Offering Of 2.050% Senior Notes Due 2014 For US$300 Million
Thermo Fisher Scientific Completes Public Offering Of 3.200% Senior Notes Due 2016 For US$900 Million
Thermo Fisher Scientific Acquires Finesse Solutions
Thermo Fisher Scientific Acquires FEI for USD4.2 Billion
Thermo Fisher Scientific May Acquire Illumina for USD30 Billion
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion
Thermo Fisher Scientific Acquires INEL
Thermo Fisher Scientific Acquires Advanced Scientifics for USD300 Million
FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM
EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million
Thermo Fisher Scientifi
Skip to top


Ask Your Question

Thermo Fisher Scientific Inc (TMO) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: